Just what we have been waiting on for a year or more….that big drug deal……this will be our biggest deal yet for affordable medication, right?
Trump and Sec of the mundane announced their new “blueprint” for lower drug prices……
Drug policy experts and price advocates on Friday panned a long-overdue speech by Donald Trump on drug prices.
As part of the speech, the US health secretary, Alex Azar, suggested drug companies should be required to disclose pharmaceutical prices in advertisements as an incentive to set lower prices.
Along with the speech, the president released a “blueprint” to lower drug prices. However, many proposals had already been made public in the administration’s budget and most were technical rule changes which can be accomplished without Congress. Drug policy analysts said most the proposals would be unlikely to “materially harm industry”. Following Trump’s speech, health stocks rose.
The administration’s blueprint also proposed lifting the pharmacist “gag” rule, so pharmacists can tell consumers when a drug is cheaper without their health insurance. Such provisions are written into contracts between pharmacists and benefit managers, who act as middlemen between the consumer and the health plan.
Did you read that stocks soared because of this announcement? If this did not benefit the drug industry massively would their prices have soared? I think not!
President Trump’s long-awaited plan to bring down drug prices will mostly spare the pharmaceutical industry he previously accused of “getting away with murder” and instead focus on increasing private competition and requiring more openness about costs, per the AP. In Rose Garden remarks at the White House, Trump called his plan the “most sweeping action in history to lower the price of prescription drugs for the American people.” (The plan is here.) But it does not include his campaign pledge to use the massive buying power of the government’s Medicare program to directly negotiate lower prices for seniors. The Washington Post notes that the idea was the one feared most within the industry. The Wall Street Journal reports that drugmakers and pharmacy-benefit managers “suggested privately they were relieved to avoid harder blows from the plan.”
Instead, the administration will pursue a raft of old and new measures intended to improve competition and transparency in the drug-pricing system. Those include a proposal requiring drugmakers to disclose the cost of their medicines in their TV advertisements. Health Secretary Alex Azar said the Food and Drug Administration would immediately examine requiring that information in TV ads. The proposals also include banning the pharmacist “gag rule,” which Trump said prevents druggists from telling customers about lower-cost options so they can save money, and speeding up the approval process for over-the-counter medications so patients can buy more drugs without prescriptions. It’s an approach that avoids a direct confrontation with the powerful pharmaceutical lobby, but it could also underwhelm Americans seeking relief from escalating prescription costs.
Just another con job for the ignorant and lazy…..one good question to ask……”How the heck is this going to lower drug prices in this country?”
Officially ditching his campaign promise to challenge the pharmaceutical industry head-on and allow Medicare to negotiate lower drug prices—a betrayal that may have something to do with the fact that the White House is currently occupied by former Big Pharma executives in key posts—President Donald Trump on Friday formally unveiled a plan ostensibly aimed at cutting medicine costs that analysts and progressive critics are already slamming as wholly inadequate and “pharma-friendly.”
This is the same as it ever was…..A Huge Con Job By A Con Artist!